GH + Fat-Loss Stack | Sleep, Recovery & Lean Support

CJC NO DAC + IPA Blend

$109.95

Recommended with this product
Recommended with this product
Product total
Options total
Grand total
This product is intended for laboratory research use only. Not for human consumption.

Dosage
CJC 5 mg + IPA 5 mg (10 mg total)
Express Delivery
24 Hour from Perth
Research Dosage
250mcg – 300mcg per day (SC) / 5 days on + 2 days off
DELIVERY FROM PERTH WAREHOUSE - SAME DAY DISPATCH

Note: BAC Water is required for reconstitution with all research peptides

Express shipping

Available Australia wide

99%+ PURITY

Lab Verified

Lab Tested in USA

GMP Certified

QUALITY & TRANSPARENCY

Independent Test Results

Select a laboratory report below to review its Certificate of Analysis and verified batch data.

✓ Batch Verified
SELECTED REPORT

Certificate of Analysis

Job #367671
Ipamorelin + CJC-1295 5mg / 5mg Certificate of Analysis
REPORT DETAILS

Ipamorelin + CJC-1295 5mg / 5mg

22 Sep 2026
PURITY 99.58%
Lab / Brand Ozcanium Analytics
Strength / Result 5mg + 5mg + 5.65mg
Analysis Date 22 Sep 2026
Report Reference #367671
✓
Independent laboratory report

Report information shown here is linked directly to this product's COA record.

Additional pages: Page 2 ↗ Page 3 ↗
TESTING HISTORY

Available COA Reports

Select any report to update the preview above.

Ipamorelin + CJC-1295 5mg / 5mg COA Latest Selected
22 Sep 2026 #367671

Ipamorelin + CJC-1295 5mg / 5mg

Lab Ozcanium Analytics Purity 99.58%
View report →

What is CJC NO DAC + IPA Blend

Injectable Research Peptide Australia

Global Peptide Sciences supplies CJC 1295 No DAC + Ipamorelin blend in Australia, manufactured under GMP-aligned laboratory standards and verified through independent third-party testing. This formulation combines CJC 1295 No DAC (Modified GRF 1–29) with Ipamorelin in a research-grade injectable format designed for controlled laboratory investigation.

Researchers looking to buy CJC 1295 No DAC with ipamorelin peptide online in Australia can access a lab-tested peptide blend supported by full Certificate of Analysis (COA) documentation.

Research Overview: CJC 1295 No DAC & Ipamorelin

CJC 1295 No DAC, also known as Modified GRF 1–29, is widely studied in peptide research for its role in pulsatile growth hormone signalling. When paired with Ipamorelin, this combination is frequently researched for its synergistic interaction within controlled experimental settings.

This CJC 1295 No DAC and Ipamorelin blend is commonly investigated in research exploring:

  • Lean mass regulation pathways
  • Metabolic signalling mechanisms
  • Hormone rhythm modulation
  • Recovery-related cellular processes

All studies referenced relate to laboratory research environments only.

Why Researchers Buy CJC 1295 No DAC Peptide

Professionals who buy CJC 1295 No DAC peptide typically prioritise purity, documentation, and manufacturing standards. Our injectable research peptide is supplied in sterile, lyophilised form to maintain stability during shipping and storage.

Each vial is:

  • Third-party tested
  • Verified via HPLC and LC-MS analysis
  • Manufactured under GMP-aligned processes
  • Supplied with documented COA

As part of our injectable peptides Australia range, this product is intended strictly for research purposes.

Quality & Compliance Standards

As a trusted supplier of injectable peptides in Australia, we ensure every batch of CJC 1295 No DAC Ipamorelin blend meets strict research-grade requirements. Transparent sourcing and independent testing help laboratories maintain consistency and reproducibility in controlled studies.

This product is not approved for human or animal consumption.

CJC 1295 No DAC Peptide Benefits

The CJC 1295 No DAC peptide is widely researched for its role in growth hormone signalling and endocrine pathway studies. When combined with Ipamorelin in controlled laboratory environments, this blend is commonly investigated for the following research-focused areas:

  • Supports lean muscle growth and fat-burning research
  • Supports sleep quality, recovery, and tissue repair processes
  • Designed to have minimal impact on cortisol and prolactin levels in research settings
  • Popular option for short-acting daily research protocols with fast-acting properties

Order CJC 1295 No DAC + Ipamorelin Blend Online

If you’re ready to buy CJC 1295 No DAC from a reliable Australian supplier, explore our verified research peptide range today. Global Peptide Sciences offers fast Australian shipping, full documentation, and professional research-focused support.

Browse now to buy injectable peptides online with confidence and secure high-purity research compounds backed by scientific standards.

Research Applications

GH Pulse + Ghrelin Receptor Synergy

Researchers study this blend to explore:

  • Combined GHRH + GHRP signaling pathways
  • Enhanced GH pulse amplitude and frequency
  • Improved recovery pathways through pulsatile GH release

Body Composition & Recovery Research

Laboratory studies explore:

  • Lean mass preservation and fat-burning support
  • Sleep quality changes through GH pulse timing
  • Reduced risk of elevated prolactin/cortisol compared to older GHRPs

Previous Research Dosage Used

Some previous research has shown great results on a dose range of 250mcg – 300mcg per day just before going to sleep on an empty stomach (no food for 90 minutes).

Taken 5 days straight then 2 days off.

Best taken on an empty stomach before bed.

Certificate of Analysis

QUALITY & TRANSPARENCY

Independent Test Results

Select a laboratory report below to review its Certificate of Analysis and verified batch data.

✓ Batch Verified
SELECTED REPORT

Certificate of Analysis

Job #367671
Ipamorelin + CJC-1295 5mg / 5mg Certificate of Analysis
REPORT DETAILS

Ipamorelin + CJC-1295 5mg / 5mg

22 Sep 2026
PURITY 99.58%
Lab / Brand Ozcanium Analytics
Strength / Result 5mg + 5mg + 5.65mg
Analysis Date 22 Sep 2026
Report Reference #367671
✓
Independent laboratory report

Report information shown here is linked directly to this product's COA record.

Additional pages: Page 2 ↗ Page 3 ↗
TESTING HISTORY

Available COA Reports

Select any report to update the preview above.

Ipamorelin + CJC-1295 5mg / 5mg COA Latest Selected
22 Sep 2026 #367671

Ipamorelin + CJC-1295 5mg / 5mg

Lab Ozcanium Analytics Purity 99.58%
View report →

Chemical Structure

This product is a two-peptide blend, combining a short-acting GHRH analog (CJC-1295 No DAC) with a selective ghrelin receptor agonist (Ipamorelin). Because it contains multiple peptides, the blend does not have one single molecular formula or molecular weight — instead, each component has its own defined molecular specifications.
Purity≥99%
AppearanceWhite lyophilized powder blend
StorageStore at -20°C
FormLyophilized injectable peptide blend

Key Structural Characteristics

  • Combines GHRH + GHRP mechanisms to support pulse-based GH research
  • Short-acting formulation supports timing precision and daily protocols
  • Component-specific molecular specs allow accurate research tracking